This inventor holds 1 USPTO granted patent. Top assignee: James Black Foundation Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: David Andrew Sykes: Innovator in Receptor Ligands
Introduction
David Andrew Sykes is a distinguished inventor based in London, Great Britain. With a significant contribution to the field of biochemistry, he holds a patent that reflects his innovative thinking and deep understanding of receptor ligands.
Latest Patents
Sykes's latest patent focuses on "Gastrin and cholecystokinin receptor ligands," showcasing his expertise in developing compounds that could have important implications in the medical field.
Career Highlights
Currently, David Sykes works at the James Black Foundation Limited, a research institution known for its commitment to advancing healthcare through scientific innovation. His work there highlights his dedication to improving drug discovery and therapeutic development.
Collaborations
Throughout his career, Sykes has collaborated with notable colleagues such as Sarkis Barret Kalindjian and Ildiko Maria Buck. These collaborations have likely enhanced his research outputs and expanded the scope of his innovations in receptor biology.
Conclusion
David Andrew Sykes stands out as a valuable inventor in the scientific community, particularly in his area of expertise. His work on gastrin and cholecystokinin receptor ligands continues to pave the way for future developments in therapeutic applications. His contributions at the James Black Foundation Limited further reflect his commitment to advancing health science through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile